OnCo
trialsTrial

Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia

A phase 3 trial of Cladribine, Daunorubicin and Mitoxantrone in Acute myeloid leukaemia, run by dr hab. n. med. Agnieszka Wierzbowska, with a status the registry has not verified recently.